Structures by: Fernández D.
Total: 24
(Au4(PP3)I4).2DMSO
C92H108Au8I8O4P8S4
Dalton Transactions (2008) 19 2633-2642
a=25.449(5)Å b=23.715(5)Å c=20.506(5)Å
α=90.000(5)° β=112.735(5)° γ=90.000(5)°
(Au4(PP3)Br4).2H2O
C42H42Au4Br4O2P4
Dalton Transactions (2008) 19 2633-2642
a=25.795(9)Å b=24.108(9)Å c=20.483(7)Å
α=90.00° β=113.905(6)° γ=90.00°
Ag2(tripod)I2.3DMSO
C41H39Ag2I2P3
J. Chem. Soc., Dalton Trans. (2002) 6 1110-1118
a=13.926(4)Å b=19.209(5)Å c=19.642(5)Å
α=90.00° β=98.190(5)° γ=90.00°
Ag(tripod)Cl.2DMF
C47H53Ag2Cl2N2O2P3
J. Chem. Soc., Dalton Trans. (2002) 6 1110-1118
a=18.060(3)Å b=14.866(3)Å c=18.468(4)Å
α=90.00° β=105.862(4)° γ=90.00°
Ag(tripod)Br
C41H39Ag2Br2P3
J. Chem. Soc., Dalton Trans. (2002) 6 1110-1118
a=19.486(3)Å b=9.7523(13)Å c=20.388(3)Å
α=90.00° β=95.638(4)° γ=90.00°
(+-)-1-[(cyclohexyloxy)carbonyloxy]ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole- 7-carboxylate
C33H34N6O6
Acta Crystallographica Section E (2005) 61, 2 o309-o312
a=16.3545(4)Å b=10.8868(3)Å c=18.4635(5)Å
α=90.00° β=104.102(2)° γ=90.00°
C20H17ClN2O3
C20H17ClN2O3
Acta Crystallographica Section C (2001) 57, 7 848-850
a=8.6326(9)Å b=13.1190(10)Å c=15.505(4)Å
α=90° β=96.190(10)° γ=90°
Zn2,2C3H10NO7P21,2H2O
Zn2,2C3H10NO7P21,2H2O
Acta Crystallographica Section C (2004) 60, 2 m73-m75
a=7.3531(2)Å b=10.8223(2)Å c=10.9197(2)Å
α=90° β=94.469(2)° γ=90°
VENLAFAXINE HYDROCHLORIDE
C17H28NO2,Cl
Acta Crystallographica Section C Crystal Structure Communications (2000) 56, 8 1009-1010
a=26.230(5)Å b=5.8810(12)Å c=11.448(2)Å
α=90.00° β=90.00° γ=90.00°
DISODIUM PAMIDRONATE
2Na1,C3H9N1O7P22,5H2O
Acta Crystallographica Section C (2002) 58, 2 m77-m80
a=5.9588(4)Å b=10.9010(10)Å c=11.2900(10)Å
α=113.700(5)° β=93.164(4)° γ=91.957(5)°
Potassium 2-butyl-4-chloro-1-{[2'-(5-tetrazolido)biphenyl-4-yl]methyl}-1H-imidazol- 5-ylmethanol
K,C22H22ClN6O
Acta Crystallographica Section C (2002) 58, 7 m418-m420
a=15.5724(3)Å b=7.4976(2)Å c=24.2640(5)Å
α=90° β=128.4980(10)° γ=90°
Ca2,2C3H10NO7P2,2H2O
Ca2,2C3H10NO7P2,2H2O
Acta Crystallographica Section C (2002) 58, 10 m494-m497
a=14.2921(9)Å b=14.2755(9)Å c=11.1465(7)Å
α=90° β=119.0310(10)° γ=90°
C3H11NO6P2
C3H11NO6P2
Acta Crystallographica Section C (2003) 59, 6 o289-o292
a=11.666(3)Å b=12.937(5)Å c=5.714(3)Å
α=90° β=90° γ=90°
C5H13NO7P2,2H2O
C5H13NO7P2,2H2O
Acta Crystallographica Section C (2003) 59, 6 o289-o292
a=11.8880(3)Å b=12.4715(4)Å c=7.9403(2)Å
α=90° β=95.4986(13)° γ=90°
C22H28O5
C22H28O5
Acta Crystallographica Section C (2003) 59, 4 o187-o189
a=11.4372(4)Å b=7.8901(3)Å c=21.1268(9)Å
α=90° β=97.896(2)° γ=90°
C7H17NO7P2
C7H17NO7P2
Acta Crystallographica Section C (2003) 59, 5 o228-o230
a=9.9208(16)Å b=10.7754(19)Å c=11.4933(17)Å
α=90° β=106.439(11)° γ=90°
Ca2,2C4H12NO7P21
Ca2,2C4H12NO7P21
Acta Crystallographica Section C (2003) 59, 12 m543-m545
a=15.9236(7)Å b=12.4044(6)Å c=11.4378(5)Å
α=90° β=123.516(2)° γ=90°
C28H28NO4S1,Cl1
C28H28NO4S1,Cl1
Acta Crystallographica Section C (2001) 57, 9 1092-1094
a=13.4836(3)Å b=13.1345(3)Å c=14.6532(3)Å
α=90° β=102.0570(13)° γ=90°
1-hydroxy-1-phosphono-3-(1-piperidino)propylidene-1-phosphonate
C8H19NO7P2
Acta Crystallographica Section C (2003) 59, 12 o661-o663
a=10.590(4)Å b=11.490(3)Å c=11.344(5)Å
α=90° β=116.58(3)° γ=90°
[Pt(PP3)CN]CN.H2O
C44H42N2OP4Pt
Inorganic Chemistry (2002) 41, 4435-4443
a=10.306(4)Å b=10.488(4)Å c=21.012(8)Å
α=80.411(6)° β=86.458(6)° γ=76.204(6)°
[Pt(PP3)(SnCl3)](SnCl3).CHCl3
C43H42Cl9P4PtSn2
Inorganic Chemistry (2002) 41, 4435-4443
a=12.514(3)Å b=42.380(11)Å c=10.552(3)Å
α=90.00° β=113.165(4)° γ=90.00°
[Pt(PP3)Cl]Cl.6H2O
C42H42Cl2O5.5P4Pt
Inorganic Chemistry (2002) 41, 4435-4443
a=10.275(2)Å b=10.630(2)Å c=20.770(4)Å
α=80.244(4)° β=86.006(4)° γ=75.924(4)°
[Pd(PP3)Cl]2(SnPh2Cl4).4H2O
C48H47Cl3O2P4PdSn0.5
Inorganic Chemistry (2002) 41, 4435-4443
a=10.112(2)Å b=12.028(3)Å c=21.282(5)Å
α=92.903(4)° β=101.721(4)° γ=111.854(4)°
C42H42AgClNP3
C42H42AgClNP3
J. Chem. Soc., Dalton Trans. (2002) 6 1110-1118
a=8.895(4)Å b=10.339(4)Å c=10.809(4)Å
α=74.50(2)° β=80.92(2)° γ=79.66(2)°